Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Phase 2 Study of AD-810N (zonisamide) in Parkinsonism in Dementia with Lewy Bodies
jRCT2080221994Phase 2
- Sponsor
- Sumitomo Pharma
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of zonisamide in dementia with Lewy bodies (DLB), sponsored by Sumitomo Pharma.
02
Drugs
zonisamide
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on jRCT2080221994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221994.